Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma

Cancer

Volumn 106, Issue 7, 2006, Pages 1536-1547

  Kasperts, Nicolien ^a   Slotman, Ben J ^a   Leemans, C Rene ^a   De Bree, Remco ^a   Doornaert, Patricia ^a   Langendijk, Johannes A ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Locoregional control; Postoperative reirradiation; Quality of life; Second primary tumors; Survival; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LARYNX DISORDER; MALE; METASTASIS; MUCOSA INFLAMMATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RECURRENT CANCER; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIATION INJURIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645830070     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21768     Document Type: Article

References (22)

1. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992;28:426-430.
2. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933-1938.
3. Bartelink H, Breur K, Hart G, Annyas B, van Slooten E, Snow G. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer. 1983;52:1008-1013.
4. Huang DT, Johnson CR, Schmidt-Ullrich R, Grimes M. Post-operative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys. 1992;23:737-742.
5. Lundahl RE, Foote RL, Bonner JA, et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 1998;40:529-534.
6. Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys. 1987;13:833-837.
7. Mantravadi RV, Haas RE, Liebner EJ, Skolnik EM, Applebaum EL. Postoperative radiotherapy for persistent tumor at the surgical margin in head and neck cancers. Laryngoscope. 1983;93:1337-1340.
8. O'Brien CJ, Smith JW, Soong SJ, Urist MM, Maddox WA. Neck dissection with and without radiotherapy: prognostic factors, patterns of recurrence, and survival. Am J Surg. 1986;142:456-463.
9. Carter RL, Bliss JM, Soo KC, O'Brien CJ. Radical neck dissection for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys. 1987;13:825-832.
10. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
11. Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol. 1994;33:879-885.
12. Forastiere A, Metch B, Schuller D, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 1992;10:1245-1251.
13. Jacobs C, Lyman G, Velez-Garcia E, et al. A Phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin-Oncol. 1992;10:257-263.
14. Kish JA, Weaver A, Jacobs J. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer. 1984;53:1819-1824.
15. Wang CC, Schultz M. Management of locally recurrent carcinoma of the nasopharynx. Radiology. 1966;86:900-903.
16. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys. 1987;13:953-956.
17. Stevens KR, Britsch A, Moss WT. High-dose re-irradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys. 1994;29:687-698.
18. Emami B, Bignardi M, Spector GJ, Devineni VR, Hederman MA. Reirradiation of recurrent head and neck cancers. Laryngoscope. 1987;97:85-88.
19. De Crevoisier R, Domenge C, Wibault P, Koscielny S, Lusinchi A, Janot F. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer. 2001;91:2071-2076.
20. Awwad HK, Lotayef M, Shouman T, Begg AC, Wilson G, Bentzen SM. Accelerated hyperfractionated (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Br J Cancer. 2002;86:517-523.
21. Cooper JS, Pajak TF, Forestiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med. 2004;350:1337-1344.
22. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952.